Biases and Relevant Conflicts of Interest
The Action Collaborative serves as a neutral platform through which to facilitate dialogue and discussion among representatives from multiple sectors around topics of mutual interest and concern. Individual participating members of the Action Collaborative on Translating Emerging Science, Technology, and Innovation have disclosed any perceived or actual interests (financial, organizational, professional, or personal in nature) relevant to the activities of the Action Collaborative.
ACT-ESTI Steering Committee Members
Monica Bertagnolli declares that she has no relevant interests.
Fred Cohen declares that he has no relevant interests.
Anwesha Dey declares the following interests: employee of Genentech and a shareholder at Roche.
Gianrico Farrugia declares that he has no relevant interests.
Scott Gottlieb declares that he has no relevant interests.
Stephen Hahn declares the following interests: Advisor/Board of Directors/Stockholder in: Nucleus RadioPharma, Singletto, Alpha Tau, H1, VieCure, Faeth Therapeutics, YourBio, Flick, Veravas, Repertoire, Pathway Drugs, Telperian, Catalytic IP, IntraBio, MyJeeva.
Paula Hammond declares that she has no relevant interests.
Peter Lee declares the following interest: employee of Microsoft Corporation.
Theresa Maldonado declares that she has no relevant interests.
Alondra Nelson declares the following interests: Board Member, MacArthur Foundation; Board Member, New York Genome Center; Board Member, Mozilla; Member, National Science Board.
Tim Persons declares that he has no relevant interests.
Steve Quake declares that he has no relevant interests.
Randy Rutta declares that he has no relevant interests.
Lynda Stuart Statement on relevant interests forthcoming
Holden Thorp declares the following interests: Venture partner at Hatteras Venture Partners, consultant to Ancora Partners, consultant to Urban Impact Advisers.
Chris Viehbacher declares that he has no relevant interests.
Keith Wailoo declares that he has no relevant interests.
David Winickoff declares the following interest: serves as official of the OECD, an international organization, but sees no conflict.
Culture of Innovation Working Group
Amy Abernethy, MD, PhD, declares the following interests: Cofounder, Highland Health; Owner, Target RWE; Corporate Board of Directors: Georgiamune, insitro, OneHealth; Board of Trustees, Duke university; Scientific Advisory Board: Arsenal Capital, Sixth Street, Lore, ClavystBio, Switchback Therapeutics; Significant personal ownership: Revolution Medicines, Ataraxis, Inductive Bio, Alara Gateway, IndiGov, Iterative Health, Parkway VC, Character VC, Layout VC, General Catalyst, and Penny Jar.
Elena Fuentes-Afflick, MD, MPH, declares that she has no relevant interests.
Cinnamon S. Bloss, PhD, declares that she has no relevant interests.
Hana El-Samad, PhD, declares that she has no relevant interests.
Juan Enriquez, MBA, declares the following interests: Partner, venture fund that invests in leading edge technologies; Gives paid lectures on future focused topics.
Rachel E. Fabi, PhD, declares that she has no relevant interests.
Andrew Gonzalez, MD, JD, MPH, declares the following interests: Stock Shareholder of NVIDIA, Apple, ARM Holdings, Google, Gorilla Networks, Palo Alto Networks.
Anthony Ryan Hatch, PhD, declares that he has no relevant interests.
Mariell Jessup, MD, declares the following interests: Full-time employment, American Heart Association.
Sarah Hollingsworth Lisanby, MD, declares that she has no relevant interests.
Jianying Hu, PhD, declares that he has no relevant interests.
Alex John London, PhD, declares that he has no relevant interests.
Anaeze Offodile, MD, MPH, declares the following interests: Advisory Board Member, Peterson Health Technology Institute which scrutinizes AI and emerging technologies deployment in health care.
Santa J. Ono, PhD, MS, declares that he has no relevant interests.
Tim Stockwell, PhD, declares the following interests: Employed, Thermo Fisher Scientific; Owns Thermo Fisher scientific stock; Participates in employee stock purchase plan and long-term incentive program.
Kaushik Sunder Rajan, PhD, Statement on relevant interests forthcoming.
Julie A. Rosen, PhD, declares that she has no relevant interests.
Kevin Sia, PhD, declares the following interests: The Doris Duke Foundation is a supporter of the National Academies’ work on Commission on Investment Imperatives for a Healthy Nation.
Sharon Terry, MA, declares that she has no relevant interests.
Winfred Williams, MD, Statement on relevant interests forthcoming.
Devin Woods, MA, Statement on relevant interests forthcoming.
Technology Assessment Working Group
Sindy Escobar Alvarez, PhD, declares the following interests: employed, Doris Duke Foundation.
David A. Asch, MD, MBA, declares the following interests: Employee, University of Pennsylvania; Partner and part owner VAL Health (behavioral economics consulting); Advisor, Thrive Global (wellness); Advisor, Select.Dr (physician selecting company); Board Member ROCS Foundation (medical education).
Hutan Ashrafian, PhD, MBBS, MBA, declares the following interests: Chief Medical Officer, Harbinger Health.
Arturo Casadevall, MD, PhD, declares the following interests: Founder, Melatech Space; Scientific Advisory Board, SabTherapeutics.
Elliot L Chaikof, MD, PhD, declares that he has no relevant interests.
Ivan Glenn Cohen, JD, declares the following interests: Chair of the Ethics Advisory Board, Illumina; Member, Bayer Bioethics Council; Member, Bexorg Bioethics Advisory Group; Advisor, World Class Health; Compensated for speaking at events organized by Philips, the Washington Post, and the Doctors Company, attending the Transformational Therapeutics Leadership Forum organized by Galen Atlantica, and retained as an expert in health privacy, gender-affirming care, and reproductive technology lawsuits.
Robert Cook-Deegan, MD, declares that he has no relevant interests.
Tim Evans, MD, DPhil, declares that he has no relevant interests.
Nita Farahany, PhD, JD, Statement on relevant interests forthcoming.
Lee A. Fleisher, MD, declares the following interests: CEO of Rubrum Advising, which assists medical device companies get market access.
Jeffrey Kahn, PhD, MPH, declares that he has no relevant interests.
Lydia Kavraki, PhD, declares that she has no relevant interests.
Robert Kocher, MD, declares the following interests: Director, Aldeade; Director, Lyra Health; Director, Premera Blue Cross; Director, Virta Health; Director, Devoted Health; Director, Candid; Director, Accompany Health; Director, Need Health; Board Observer, Stride Health; Board Observer, Suki; Board Observer, Public Health Company; Board Observer, SmithRx; Trustee, Castilleja School; Advisory Board, Schaeffer Center for Health Policy at USC; Advisory Board, Stanford Health Policy Advisory Board.
Esther Krofah, MPP, Statement on relevant interests forthcoming.
Cara LaPointe, PhD, MPhil, MS, Statement on relevant interests forthcoming.
Debra Mathews, PhD, MA, declares that she has no relevant interests.
Anaeze Offodile, MD, MPH, declares the following interests: Advisory Board Member, Peterson Health Technology Institute which scrutinizes AI and emerging technologies deployment in health care.
Arti Rai, JD, declares that she has no relevant interests.
Krystal Tsosie, PhD, MS, MA, declares the following interests: Speaker’s renumeration for invited guest talk at AbbVie pharmaceuticals (2024) relationship ended; Volunteer non-compensated executive board membership, the Native BioData Consortium; Volunteer non-compensated board membership, American Society of Human Genetics.
